Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Trials

28 Apr 2008 08:09

Plant Health Care PLC28 April 2008 For immediate release 28 APRIL 2008 PLANT HEATH CARE PLC ("Plant Heath Care" or "the Company") Plant Health Care, Inc. initiates large scale grower tests for a ProActTM + Glyphosate product Plant Heath Care, (AIM: PHC.L), a leading provider of natural products forplants and soil, has initiated a large scale field trial program for corn,soybeans, and cotton to further evaluate the already established benefits ofusing ProActTM in combination with glyphosate, the world's most commonly usedherbicide, when applied over-the-top of glyphosate resistant crops. Five yearsof independent testing have demonstrated significant yield increases in cottonand corn when treated with a combination of ProAct and glyphosate. ProAct is afoliar spray product for reducing nematode populations and improving overallplant health. ProAct, which is the only foliar spray product labeled for useagainst nematodes in corn and soybeans, contains Harpin, a second generationharpin protein formulated as a wettable dry granule. PHC Director of Field Biology Ned French says, "ProAct increases yields. Thecomprehensive data from multi-year ProAct research shows average increases of2.5 bushels/acre in soybeans, 7 bushels/acre in corn, and 68 pounds of cottonlint/acre. These yield increases translate into economic returns of $28, $35,and $50/acre, respectively. The ProAct + Glyphosate Program will help bothgroups learn more about the benefits in real-world farming conditions." All participants will be asked to join a series of post-harvest teleconferencesto discuss how the ProAct + glyphosate tank-mix performed on their farms. PHCwill use the information gleaned from the teleconferences as the basis forbetter understanding farmer needs and perceptions as they relate to the use ofProAct + glyphosate. PHC, started in 1995, was originally focused on horticulture, turf, vegetablesand high value crops. The company started targeting field crops -corn, soybeans,and cotton - in 2007 based on its acquisition of harpin protein technologyproducts such as ProAct. ProAct contains the most recently developed andeffective generation of harpin proteins. Plant Health Care, Inc., headquartered in Pittsburgh, PA, is a wholly ownedsubsidiary of Plant Health Care plc (AIM:PHC), a leading provider of naturalproducts for plants and soil. PHC has operations in the United States, Mexico,the United Kingdom, Spain, and the Netherlands. PHC products are used in theagriculture, landscape, horticulture and land reclamation industries and areenvironmentally beneficial. Through the commercialization of these products, PHCis capitalizing on current long-term trends toward natural systems andbiological products for plant care and soil and water management. For moreinformation and complete details pertaining to the ProAct SatisfactionGuarantee, go to www.planthealthcare.com. -ends- For further information: Plant Heath Care plc John Brady, Chief Executive Tel: 001 603 525 3702 Evolution Securities Limited Tim Worlledge/ Tim Redfern Tel: 020 7071 4300 Tavistock Communications Jeremy Carey/Matt Ridsdale Tel: 020 7920 3150 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.